Table 1 Demographic data and clinical characteristics of the sample by treatment group

 Gender n, (% females)

17

(90.0)

24

(96.0)

.72

.57

 Age, M (SD)

32.95

(7.48)

32.00

(7.49)

−.41

.68

 Years of education, M (SD)

12.44

(3.97)

11.41

(3.20)

−.92

.35

 Marital status n, (% not married)

13

(68.4)

12

(48.0)

2.53

.28

 DIB-R total score, M (SD)

7.71

(.98)

8.17

(1.40)

1.16

.25

 - Anxiety Disorders

17

(89.5)

19

(76.0)

1.31

.25

 - Major Depressive Disorder

13

(68.4)

16

(64.0)

.09

.75

 - Bulimia Nervosa

12

(63.2)

9

(36.0)

3.19

.07

 - Substance Abuse Disorder

11

(57.9)

20

(80.0)

2.53

.11

 Other PD diagnosis n, (%)

9

(64.3)

16

(80.0)

1.04

.31

Pharmacological treatment

 - SSRI n, (%)

15

(78.9)

14

(66.7)

.75

.38

 - Benzodiazepines n, (%)

9

(47.4)

12

(57.1)

.38

.53

 - Mood stabilizers n, (%)

2

(10.5)

1

(4.8)

.47

.48

 - Antipsychotics n, (%)

8

(42.1)

9

(42.9)

.00

.96